These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32398093)

  • 1. Access to routinely collected health data for clinical trials - review of successful data requests to UK registries.
    Lensen S; Macnair A; Love SB; Yorke-Edwards V; Noor NM; Martyn M; Blenkinsop A; Diaz-Montana C; Powell G; Williamson E; Carpenter J; Sydes MR
    Trials; 2020 May; 21(1):398. PubMed ID: 32398093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of routinely collected data in a UK cohort of publicly funded randomised clinical trials.
    McKay AJ; Jones AP; Gamble CL; Farmer AJ; Williamson PR
    F1000Res; 2020; 9():323. PubMed ID: 33163157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of routinely collected health data in randomised clinical trials: comparison of trial-specific death data in the BOSS trial with NHS Digital data.
    Love SB; Kilanowski A; Yorke-Edwards V; Old O; Barr H; Stokes C; Kendall C; Sydes MR
    Trials; 2021 Sep; 22(1):654. PubMed ID: 34565428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using routine data to complement and enhance the results of randomised controlled trials.
    Lewsey JD; Leyland AH; Murray GD; Boddy FA
    Health Technol Assess; 2000; 4(22):1-55. PubMed ID: 11074392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using routinely recorded data in the UK to assess outcomes in a randomised controlled trial: The Trials of Access.
    Powell GA; Bonnett LJ; Tudur-Smith C; Hughes DA; Williamson PR; Marson AG
    Trials; 2017 Aug; 18(1):389. PubMed ID: 28835254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can randomised trials rely on existing electronic data? A feasibility study to explore the value of routine data in health technology assessment.
    Williams JG; Cheung WY; Cohen DR; Hutchings HA; Longo MF; Russell IT
    Health Technol Assess; 2003; 7(26):iii, v-x, 1-117. PubMed ID: 14499049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model.
    Pufulete M; Maishman R; Dabner L; Mohiuddin S; Hollingworth W; Rogers CA; Higgins J; Dayer M; Macleod J; Purdy S; McDonagh T; Nightingale A; Williams R; Reeves BC
    Health Technol Assess; 2017 Aug; 21(40):1-150. PubMed ID: 28774374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accessing routinely collected health data to improve clinical trials: recent experience of access.
    Macnair A; Love SB; Murray ML; Gilbert DC; Parmar MKB; Denwood T; Carpenter J; Sydes MR; Langley RE; Cafferty FH
    Trials; 2021 May; 22(1):340. PubMed ID: 33971933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 blocking agents for treating COVID-19: a living systematic review.
    Ghosn L; Chaimani A; Evrenoglou T; Davidson M; Graña C; Schmucker C; Bollig C; Henschke N; Sguassero Y; Nejstgaard CH; Menon S; Nguyen TV; Ferrand G; Kapp P; Riveros C; Ávila C; Devane D; Meerpohl JJ; Rada G; Hróbjartsson A; Grasselli G; Tovey D; Ravaud P; Boutron I
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013881. PubMed ID: 33734435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premature trial discontinuation often not accurately reflected in registries: comparison of registry records with publications.
    Alturki R; Schandelmaier S; Olu KK; von Niederhäusern B; Agarwal A; Frei R; Bhatnagar N; Hooft L; von Elm E; Briel M
    J Clin Epidemiol; 2017 Jan; 81():56-63. PubMed ID: 27614277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inadequate description of educational interventions in ongoing randomized controlled trials.
    Pino C; Boutron I; Ravaud P
    Trials; 2012 May; 13():63. PubMed ID: 22607344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
    Murji A; Whitaker L; Chow TL; Sobel ML
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.
    Gates M; Pillay J; Nuspl M; Wingert A; Vandermeer B; Hartling L
    Syst Rev; 2023 Mar; 12(1):51. PubMed ID: 36945065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability of Trial Information Across Registries for Trials With Multiple Registrations: A Systematic Review.
    Speich B; Gloy VL; Klatte K; Gryaznov D; Taji Heravi A; Ghosh N; Marian IR; Lee H; Mansouri A; Lohner S; Saccilotto R; Nury E; Chan AW; Blümle A; Odutayo A; Hopewell S; Briel M;
    JAMA Netw Open; 2021 Nov; 4(11):e2128898. PubMed ID: 34724557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
    Chai KL; Valk SJ; Piechotta V; Kimber C; Monsef I; Doree C; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 Oct; 10():CD013600. PubMed ID: 33044747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Registration of noncommercial randomised clinical trials: the feasibility of using trial registries to monitor the number of trials.
    Raftery J; Fairbank E; Douet L; Dent L; Price A; Milne R; Walley T
    Trials; 2012 Aug; 13():140. PubMed ID: 22906196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol for a scoping review of post-trial extensions of randomised controlled trials using individually linked administrative and registry data.
    Fitzpatrick T; Perrier L; Tricco AC; Straus SE; Jüni P; Zwarenstein M; Lix LM; Smith M; Rosella LC; Henry DA
    BMJ Open; 2017 Feb; 7(2):e013770. PubMed ID: 28213601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
    Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.